-+ 0.00%
-+ 0.00%
-+ 0.00%

Kazia Therapeutics files beneficial ownership statement for Chief Scientific Officer Sudha Rao

PUBT·05/19/2026 17:07:59
Listen to the news
Kazia Therapeutics files beneficial ownership statement for Chief Scientific Officer Sudha Rao
  • Kazia Therapeutics filed an initial Form 3 for Sudha Rao in her role as chief scientific officer, dated April 13, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kazia Therapeutics Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-058882), on May 19, 2026, and is solely responsible for the information contained therein.